The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort
Abstract
Background The prevalence of diabetes is increasing in young adults in Asia, but little is known about metabolic control or the burden of associated complications in this population. We assessed the prevalence of young-onset versus late-onset type 2 diabetes, and associated risk factors and complication burdens, in the Joint Asia Diabetes Evaluation (JADE) cohort.Methods JADE is an ongoing prospective cohort study. We enrolled adults with type 2 diabetes from 245 outpatient clinics in nine Asian countries or regions. We classified patients as having young-onset diabetes if they were diagnosed before the age of 40 years, and as having late-onset diabetes if they were diagnosed at 40 years or older. Data for participants' first JADE assessment was extracted for cross-sectional analysis. We compared clinical characteristics, metabolic risk factors, and the prevalence of complications between participants with young-onset diabetes and late-onset diabetes.Findings Between Nov 1, 2007, and Dec 21, 2012, we enrolled 41,029 patients (15,341 from Hong Kong, 9107 from India, 7712 from Philippines, 5646 from China, 1751 from South Korea, 705 from Vietnam, 385 from Singapore, 275 from Thailand, 107 from Taiwan). 7481 patients (18%) had young-onset diabetes, with age at diagnosis of mean 32·9 years [SD 5·7] versus 53·9 years [9·0] with late-onset diabetes (n=33,548). Those with young-onset diabetes had longer disease duration (median 10 years [IQR 3-18]) than those with late-onset diabetes (5 years [2-11]). Fewer patients with young-onset diabetes achieved HbA1c concentrations lower than 7% compared to those with late-onset diabetes (27% vs 42%; p<0·0001) Patients with young-onset diabetes had higher mean concentrations of HbA1c (mean 8·32% [SD 2·03] vs 7·69% [1·82]; p<0·0001), LDL cholesterol (2·78 mmol/L [0·96] vs 2·74 [0·93]; p=0·009), and a higher prevalence of retinopathy (1363 [20%] vs 5714 (18%); p=0·011) than those with late-onset diabetes, but were less likely to receive statins (2347 [31%] vs 12,441 [37%]; p<0·0001) and renin-angiotensin-system inhibitors (1868 [25%] vs 9665 [29%]; p=0·006).Interpretation In clinic-based settings across Asia, one in five adult patients had young-onset diabetes. Compared with patients with late-onset diabetes, metabolic control in those with young-onset diabetes was poor, and fewer received organ-protective drugs. Given the risk conferred by long-term suboptimum metabolic control, our findings suggest an impending epidemic of young-onset diabetic complications.Funding The Asia Diabetes Foundation (ADF) and Merck.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Only 27% of subjects achieved a HbA1c <7%”
From Type 2 diabetes in adolescents and young adults (2018) · cites this paper as Yeung et al (2014)
Citations
Cites
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Prevalence and Control of Diabetes in Chinese Adults
Xu, Y. (2013) · JAMA · doi:10.1001/jama.2013.168118 · Cited by 2,703
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
Diabetes in Asia: Epidemiology, Risk Factors, and Pathophysiology
Chan, J. C. N., Malik, V., Jia, W., Kadowaki, T., Yajnik, C. S., Yoon, K.-H., & Hu, F. B. (2009) · JAMA · doi:10.1001/jama.2009.726 · Cited by 1,997
Self-citationAchievement of Goals in U.S. Diabetes Care, 1999–2010
Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1213829 · Cited by 979
Cited by
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s006 · Cited by 1,403
6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s006 · Cited by 847
Type 2 diabetes in adolescents and young adults
Lascar, N., Brown, J., Pattison, H., Barnett, A. H., Bailey, C. J., & Bellary, S. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30186-9 · Cited by 824
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Self-citation6. Glycemic Targets: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s006 · Cited by 744
Metadata
- Authors
- Yeung, R. O., Zhang, Y., Luk, A., Yang, W., Sobrepena, L., Yoon, K.-H., Aravind, S. R., Sheu, W., Nguyen, T. K., Ozaki, R., Deerochanawong, C., Tsang, C. C., Chan, W.-B., Hong, E. G., Do, T. Q., Cheung, Y., Brown, N., Goh, S. Y., Ma, R. C., Mukhopadhyay, M., Ojha, A. K., Chakraborty, S., Kong, A. P., Lau, W., Jia, W., Li, W., Guo, X., Bian, R., Weng, J., Ji, L., Rosa, M. R.-D., Toledo, R. M., Himathongkam, T., Yoo, S.-J., Chow, C. C., Ho, L. L., Chuang, L.-M., Tutino, G., Tong, P. C., So, W.-Y., Wolthers, T., Ko, G., Lyubomirsky, G., & Chan, J. C. N.
- Affiliations
- Chinese University of Hong Kong (HK)
- Prince of Wales Hospital (CN)
- China-Japan Friendship Hospital (CN)
- Catholic University of Korea (KR)
- Diacon Hospital (IN)
- Taichung Veterans General Hospital (TW)
- University of Medicine and Pharmacy at Ho Chi Minh City (VN)
- Rajavithi Hospital (TH)
- Alice Ho Miu Ling Nethersole Hospital (CN)
- Hallym University (KR)
- Asia Diabetes Foundation (CN)
- Singapore General Hospital (SG)
- Institute of Post Graduate Medical Education and Research (IN)
- Shanghai Jiao Tong University (CN)
- Peking Union Medical College Hospital (CN)
- Jiangsu Province Hospital (CN)
- Sun Yat-sen University (CN)
- Peking University People's Hospital (CN)
- Tondo Medical Center (PH)
- The Catholic University of Korea Bucheon St. Mary's Hospital (KR)
- Taipei Veterans General Hospital (TW)
- National Taiwan University (TW)
- Hong Kong Association of Registered Tour Co-ordinators (CN)
- ORCID
- Yeung, Roseanne O
- Zhang, Yuying
- Luk, Andrea
- Yang, Wenying
- Yoon, Kun-Ho
- Aravind, S R
- Sheu, Wayne
- Ozaki, Risa
- Deerochanawong, Chaicharn
- Chan, Wing-Bun
- Goh, Su Yen
- Kong, Alice P
- Lau, Winnie
- Jia, Weiping
- Li, Wenhui
- Guo, Xiaohui
- Bian, Rongwen
- Weng, Jianping
- Ji, Linong
- Himathongkam, Thep
- Chow, C C
- Chuang, Lee-Ming
- Tutino, Greg
- Ko, Gary
- Chan, Juliana C N
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 2
- Issue
- 12
- Pages
- 935-943
- ISSN
- 2213-8587 (ISSN-L)
- OpenAlex
- W2147391073
- Cited by
- 296
- References
- 34
- Citations by year
- 2026: 10 · 2025: 32 · 2024: 25 · 2023: 35 · 2022: 36 · 2021: 25 · 2020: 40 · 2019: 16 · 2018: 16 · 2017: 24 · 2016: 21 · 2015: 10 · 2014: 5
- FWCI
- 16.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet Diabetes & Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Melbourne
- University of British Columbia
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- youth-onset type 2 diabetes, metabolic control, HbA1c, LDL cholesterol, diabetes complications, diabetic nephropathy, diabetic retinopathy, diabetic neuropathy, treatment gap, glycemic control, disease duration, diabetes prevalence, risk factors, diabetes care costs
- MeSH terms
- Adult, Age Factors, Asia, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Odds Ratio, Diabetes Complications, Metabolome, Epidemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. https://app.cochat.ai/papers/10.1016/s2213-8587(14)70137-8
- The paper
- Yeung, R. O., Zhang, Y., Luk, A., Yang, W., Sobrepena, L., Yoon, K.-H., Aravind, S. R., Sheu, W., Nguyen, T. K., Ozaki, R., Deerochanawong, C., Tsang, C. C., Chan, W.-B., Hong, E. G., Do, T. Q., Cheung, Y., Brown, N., Goh, S. Y., Ma, R. C., . . . Chan, J. C. N. (2014). Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(14)70137-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.